drugset / Trial / NCT00441207

Study of High-Dose Intravenous (IV) Vitamin C Treatment in Patients With Solid Tumors

NCT00441207

Phase 1 Completed 18 enrolled Midwestern Regional Medical Center
NaSingle-groupOpen-labelTreatment

Summary

The primary purpose of this study is to evaluate the safety and tolerability of vitamin C (ascorbic acid) given by injection into the vein. The second and third purpose of conducting this study is to observe any evidence of tumor response to the vitamin C and compare the level of fatigue (weakness), pain control, ability to do things, and quality of life, before and after vitamin C is given.

Timeline

Start
2006-08
Primary completion
2010-07
Completion
2010-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Vitamin C Other / unclassified Intravenous

Indications